As of April 2026, CJC-1295 and Ipamorelin have been removed from the Food and Drug Administrations (FDA) Category 2 restricted list, with formal review of compounding eligibility scheduled for July 2026
Inject at the start of a planned eating day so the post-injection period aligns with your most structured nutritional intake
However, certain conditions such as digestive stress, mental/emotional stress & medication usage can reduce production making this an essential dietary nutrient (12, 13)
The Science Behind Combination Peptide Therapy Understanding why cagrilintide dosage with tirzepatide represents an interesting theoretical approach requires examining the science of combination therapy
Close monitoring includes regular nutrient labs (B12, iron, calcium, albumin), hydration status, and gastrointestinal symptoms